Eric G. Carter

This profile gathers the share dealings of Eric G. Carter across 2 companies, led by AEON Biopharma, Inc. and Adverum Biotechnologies, Inc. In total, 3 filings cover trades dated from 7 September 2017 to 17 June 2026.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 22 June 2026 came the latest disclosure, a share grant in AEON Biopharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.